Drug efflux by Breast Cancer Resistance Protein (BCRP) is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924

Lignende værker

• HER receptor signaling confers resistance to the insulin-like growth factor 1 receptor inhibitor, BMS-536924
  af: Haluska, Paul, et al.
  Udgivet: (2008)
• Expression of Insulin Receptor Isoform A and Insulin-Like Growth Factor-1 Receptor in Human Acute Myeloid Leukemia: Effect of the dual receptor inhibitor BMS-536924 in Vitro
  af: Hendrickson, Andrea E. Wahner, et al.
  Udgivet: (2009)
• The Mechanisms of Differential Sensitivity to an Insulin-like Growth Factor-1 Receptor Inhibitor (BMS-536924) and Rationale for Combining with EGFR/HER2 Inhibitors
  af: Huang, Fei, et al.
  Udgivet: (2009)
• BMS-536924 Reverses IGF-IR-induced Transformation of Mammary Epithelial Cells and Causes Growth Inhibition and Polarization of MCF7 Cells
  af: Litzenburger, Beate C., et al.
  Udgivet: (2009)
• Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression
  af: Nakanishi, Takeo, et al.
  Udgivet: (2012)